Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

22nd Century Group Inc XXII

22nd Century Group, Inc. is an agricultural biotechnology company. The Company is focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science. Additionally, the Company provide contract manufacturing services for conventional combustible tobacco products for third-party brands. The Company operates through a single segment named Tobacco. Its tobacco segment is engaged in contract manufacturing organization (CMO) customer contracts that consist of obligations to manufacture the customers' branded filtered cigars and cigarettes. The tobacco segment is engaged in the sale of its reduced nicotine content (RNC) cigarettes, sold under the brand name VLN, or research cigarettes sold under the brand name SPECTRUM. It uses plant breeding technologies, including genetic engineering, gene-editing, and molecular breeding to deliver solutions for the life science and consumer products.


NDAQ:XXII - Post by User

Post by lelianicruzon Sep 25, 2024 7:04am
43 Views
Post# 36239739

$XXII:Pioneering Innovation in the Tobacco Industry

$XXII:Pioneering Innovation in the Tobacco Industry

In the rapidly evolving tobacco industry, 22nd Century Group, Inc. ($XXII) has emerged as a leader in developing innovative smoking alternatives. The company is particularly noted for its VLN® cigarettes, which are recognized as the world’s first and only combustible cigarettes to receive the Modified Risk Tobacco Product (MRTP) designation from the U.S. Food and Drug Administration (FDA). This landmark achievement positions 22nd Century Group at the forefront of a market increasingly focused on reducing harm and promoting safer smoking options.

VLN® Cigarettes: A Revolutionary Product

VLN® cigarettes are engineered to contain significantly lower levels of nicotine—up to 95% less than traditional cigarettes. This product targets adult smokers who seek to reduce their nicotine intake or quit smoking altogether. The MRTP designation from the FDA indicates that VLN® has the potential to benefit public health by reducing the risk of addiction and offering a safer smoking experience.

  • Key Features of VLN® Cigarettes:
    • Lower Nicotine Content: Designed for harm reduction.
    • FDA MRTP Designation: Recognized as a product that could positively impact public health.

A Vision for the Future

The company's mission is succinctly captured in its tagline: "Our mission is to sell the last cigarette before the 22nd Century." This statement not only reflects 22nd Century’s commitment to innovation but also underscores its dedication to transitioning smokers towards reduced-risk products. This vision aligns with the global shift toward more responsible tobacco consumption, which is increasingly appealing to investors interested in sustainable business models.

Recent Developments

On September 23, 2024, 22nd Century Group announced a significant new customer agreement to supply its Moonlight branded cigarettes to the Southeast Asia marketplace. This partnership is expected to boost factory volumes by more than 30% when fully scaled. Key points from this development include:

  • First Shipment: Anticipated in the fourth quarter of 2024.
  • Market Expansion: Potential for significant volume growth as the customer launches in critical markets throughout 2025.
  • Leadership Comments: Larry Firestone, Chairman and CEO, expressed optimism about leveraging the company’s in-house brand assets to drive growth in a region with a strong smoking culture.

As 22nd Century Group continues to innovate with products like VLN® cigarettes, its commitment to reducing tobacco-related harm positions it as a potential leader in the industry. The recent customer agreement signals a promising expansion strategy, further enhancing its growth potential in a rapidly evolving market. For investors and stakeholders, 22nd Century Group offers a forward-thinking approach in an industry poised for transformation.

<< Previous
Bullboard Posts
Next >>